Sinovac has been approved by WHO as an emergency vaccine

Cambodia Compass report, 2nd June - China's Sinovac Covid vaccine has been certified for emergency use by WHO (World Health Organization). Following Sinopharm, it is the second Chinese vaccine to get WHO approval. It allows the vaccine to be used in the Covax program, which tries to ensure that vaccines are distributed fairly.

The vaccine, which has been used in various countries, is advised for anyone over the age of 18, with a second dose given two to four weeks later. WHO stated that the vaccine "meets international standards for safety, efficacy, and production" as a result of the emergency authorization.

Sinovac has been shown in studies to prevent symptomatic disease in more than half of those vaccinated, as well as severe symptoms and hospitalization in 100% of those studied. The move to approve the Chinese vaccine for emergency use is expected to boost the Covax effort, which has been plagued by supply issues. "The world urgently requires several Covid-19 vaccinations to address the massive access disparities that exist around the world," Mariangela Simao, WHO's assistant director general for access to health products, stated.

Chile, Brazil, Indonesia, Mexico, Thailand, and Turkey are among the countries that have already received the vaccine. As of the end of May, Sinovac claims to have distributed more than 600 million doses both domestically and internationally. It claims that over 430 million dosages have been given out. Sinovac has the advantage of being able to be stored between 2-8 degrees Celsius in a regular refrigerator. As a result, Sinovac is far more valuable to impoverished countries that may not be able to store huge quantities of vaccine at low temperatures.

The decision came as the leaders of WHO, the World Trade Organization, the International Monetary Fund, and the World Bank called for a $50 billion (£35 billion) investment fund to assist combat the pandemic.

They warned in a joint statement that the globe had reached a critical juncture, and that inequities in vaccination access risked prolonging the pandemic and resulting in many more deaths. They have requested that the funds be invested in areas such as vaccine production, oxygen supplies, and Covid-19 treatments, with the funds being divided equally. They also urged wealthier countries to give vaccination doses to underdeveloped countries right away.

Source: Cambodia Compass comprehensive arrangement

Editor: Malinda         Chief Editor: Sunnie         General in Chief/Executive Producer: Nicole

Compass global site: Cambodia | Singapore | UAE | Thailand | Philippines | Myanmar | Laos